Utilizing "Proteomic Mapping" for Early Neurodegenerative...

σε πρόσθεσε στο Health

2026-01-02 12:36:48 -

Utilizing "Proteomic Mapping" for Early Neurodegenerative Detection and the Battle Against Alzheimer’s within the Biomarkers Sector for 2026

In early 2026, the most significant clinical breakthrough is the validation of blood-based "Proteomic" biomarkers for the early detection of Alzheimer’s and Parkinson’s diseases. Historically, these conditions could only be confirmed via expensive PET scans or painful lumbar punctures. New "ultra-sensitive" assays can now detect "p-tau217" and "amyloid-beta" ratios in a simple blood...

0 Σχόλια 0 Μοιράστηκε 43 Views 0 Προεπισκόπηση